Showing results (781-790 of 2,319) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|November 15, 2008
Plasma levels of osteopontin before and 24 h after percutaneous coronary interventionP Georgiadou, E K Iliodromitis, F Kolokathis, et al.Expert Opinion on Therapeutic Targets|November 15, 2008
Inflammation and the glutamate system in schizophrenia: implications for therapeutic targets and drug developmentNorbert MüllerExpert Opinion on Therapeutic Targets|November 15, 2008
Targeting PPAR as a therapy to treat multiple sclerosisJohn J Bright, Crystal C Walline, Sarvanan Kanakasabai, et al.Expert Opinion on Therapeutic Targets|July 7, 2007
Targeting pleiotropin to treat osteoarthritisRolf MentleinExpert Opinion on Therapeutic Targets|July 7, 2007
STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responsesHongwei Gao, Peter A WardExpert Opinion on Therapeutic Targets|July 7, 2007
Novel therapeutic targets in mantle cell lymphomaPeter Martin, John P LeonardExpert Opinion on Therapeutic Targets|July 7, 2007
Targeting enzyme inhibitors in drug discoveryRobert A Copeland, Mark R Harpel, Peter J TumminoExpert Opinion on Therapeutic Targets|July 7, 2007
Statins and telomere length: risk assessment and management for coronary heart diseaseAtul TiwariExpert Opinion on Therapeutic Targets|August 5, 2020
Novel therapeutic targets for amyotrophic lateral sclerosis: ribonucleoproteins and cellular autonomyYiran Wang, Rickie PataniExpert Opinion on Therapeutic Targets|August 8, 2020
Inflammasomes: a preclinical assessment of targeting in atherosclerosisJeremiah Stitham, Astrid Rodriguez-Velez, Xiangyu Zhang, et al.Pageof 232